Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Cash Flow Conversion Efficiency
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares cash flow conversion efficiency. Based on the latest financial reports, Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) has a cash flow conversion efficiency ratio of -0.738x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.73 Million) by net assets ($5.06 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (2021–2025)
Cash flow conversion efficiency of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares from 2021 to 2025. This chart illustrates how Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CUPR stock price and chart for real-time trading data and today's change.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Cash Flow Conversion Ratio Explained
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares ranked by their cash flow conversion efficiency. Also see Cuprina Holdings (Cayman) Limited Class (CUPR) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cabnet Holdings Bhd
KLSE:0191
|
0.009x |
|
Apax Global Alpha Ltd
LSE:APAX
|
0.035x |
|
SeaStar Medical Holding Corporation
NASDAQ:ICU
|
-0.697x |
|
Qwamplify SA
PA:ALQWA
|
-0.044x |
|
SSH Group Ltd
AU:SSH
|
0.196x |
|
Asra Minerals Ltd
AU:ASR
|
-0.050x |
|
Peruvian Metals Corp
V:PER
|
-0.113x |
|
US Copper Corp
V:USCU
|
-0.153x |
Annual Cash Flow Conversion Efficiency for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (2021–2025)
The table below shows the annual cash flow conversion efficiency of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares from 2021 to 2025. Review Cuprina Holdings (Cayman) Limited Class leverage flexibility ratio to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $5.06 Million | $-9.13 Million | -1.807x | -751.92% |
| 2024-12-31 | $-4.46 Million | $-1.24 Million | 0.277x | -47.95% |
| 2023-12-31 | $-2.90 Million | $-1.54 Million | 0.532x | -48.81% |
| 2022-12-31 | $-1.78 Million | $-1.85 Million | 1.040x | +220.45% |
| 2021-12-31 | $-683.52K | $-221.86K | 0.325x | -- |
About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collag… Read more